This article explores the effects of hormone replacement therapy (HRT) on cancer risk, particularly focusing on breast, endometrial, ovarian, and colorectal cancers. Long-term HRT use increases the risk of breast and endometrial cancer, with the combination of estrogen and progestin being riskier for breast cancer, though it mitigates endometrial cancer
